The Internal Revenue Service is attempting to recoup $8 million from a convicted former Rhode Island nursing home executive, signaling a warning to providers that they can be held liable for misdeeds.
Despite 12 deaths, nursing facilities denied request to be on utilities’ priority list
By
Elizabeth Newman
Jul 05, 2018
A year after Hurricane Irma killed 12 nursing home residents, senior living facilities have been under pressure to have better emergency preparedness plans during the 2018 hurricane season.
LTC friend: Scout’s honor
By
Elizabeth Newman
Jul 01, 2011
Rep. Glenn “GT” Thompson, U.S. Congress (R-PA)
Omnicare and McKesson to extend drug distribution deal
By
Elizabeth Newman
Jan 01, 2015
Omnicare Inc. and McKesson Corporation have decided to extend their agreement through 2019, which will include the sourcing and distribution of branded, specialty and generic pharmaceuticals.
Woman pleads guilty in Medicare genetic testing scheme targeting seniors
By
Elizabeth Newman
Dec 05, 2016
As interest in genetic testing rises, one woman faces 10 years in prison for a $1 million Medicare fraud scheme that lured seniors into unnecessary genetic testing.
Medicaid paying 32% less than Medicare Part D for medications
By
Elizabeth Newman
Jul 03, 2014
Medicaid is paying the lowest average price for 78 high-use and high-expenditure brand-name and generic drugs, a new federal report finds.
Greener pastures
By
Elizabeth Newman
Jun 01, 2013
After seven years, Greenfields of Geneva becomes a reality for Illinois seniors, featuring a luxurious setting overlooking a golf course.
FDA wants lower doses for sleeping aids
By
Elizabeth Newman
Feb 01, 2013
The Food and Drug Administration is requiring manufacturers of certain sleeping pills, including the widely prescribed Ambien, to reduce current recommended dosages.
Superbugs are more resistant
By
Elizabeth Newman
Sep 05, 2018
Multi-drug resistant superbugs, which can cause dangerous infections, are becoming increasingly resistant to alcohol-based hand sanitizers and disinfectants, according to an Australian study.
More effective shots created
By
Elizabeth Newman
Feb 01, 2013
New strains of genetically engineered bacteria may improve the efficacy of vaccines for diseases that include the flu and pertussis, University of Texas at Austin researchers say.